Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02215941 · ClinicalTrials.gov registry record · Phase 1
Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers
A Phase 1 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT02215941 is a Phase 1 study that has completed, run by Teva Branded Pharmaceutical Products R&D. The registered enrollment target is 45 participants.
The verdict
NCT02215941, a Phase 1 study, has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The primary objective of this study is to characterize the pharmacokinetics of TV-45070 in plasma following single and multiple-dose topical application of 8% TV-45070 ointment.
Interventions
- DRUG Placebo
- DRUG TV-45070
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02215941
The ClinicalTrials.gov registry entry for NCT02215941 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teva Branded Pharmaceutical Products R&D, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02215941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02215941 about?
NCT02215941 is a clinical study titled "Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers". The primary objective of this study is to characterize the pharmacokinetics of TV-45070 in plasma following single and multiple-dose topical application of 8% TV-45070 ointment.
What is the current status of trial NCT02215941?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2014-08. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02215941?
The interventions under investigation include: Placebo (DRUG), TV-45070 (DRUG).
Who is sponsoring clinical trial NCT02215941?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.